Cefudyne Use In Pregnancy & Lactation

Film-coated tablet: Pregnancy: There are limited data from the use of cefuroxime in pregnant women.
Cefuroxime should be prescribed to pregnant women only if the benefit outweighs the risk.
Breastfeeding: Cefuroxime is excreted in human milk in small quantities. Adverse effects at therapeutic doses are not expected, although a risk of diarrhea and fungal infection of the mucous membranes cannot be excluded. Breastfeeding might have to be discontinued due to these effects. The possibility of sensitization should be taken into account. Cefuroxime should only be used during breastfeeding after benefit/risk assessment by the physician-in-charge.
Fertility: There are no data on the effects of cefuroxime axetil on fertility in humans.
Powder for Suspension: There is no experimental evidence of embryonic or teratogenic effects attributable to cefuroxime axetil but, as with all drugs, it should be administered with caution during the early months of pregnancy. Cefuroxime is excreted in human milk, and consequently caution should be exercised when cefuroxime axetil is administered to a nursing mother.